BCHE and Alzheimer disease: The U.S. Food and Drug Administration (FDA) approved two main classes of drugs for AD, which are cholinesterase inhibitors (tacrine, donepezil, galantamine, rivastigmine) and N-methyl-D-aspartase (NMDA) receptor antagonists (memantine) [6].